Literature DB >> 21685447

Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.

YanFei Qi1, Vinayak Shenoy, Fong Wong, Hongwei Li, Aqeela Afzal, J Mocco, Colin Sumners, Mohan K Raizada, Michael J Katovich.   

Abstract

Myocardial infarction (MI) results in cell death, development of interstitial fibrosis, ventricular wall thinning and ultimately, heart failure. Angiotensin-(1-7) [Ang-(1-7)] has been shown to provide cardioprotective effects. We hypothesize that lentivirus-mediated overexpression of Ang-(1-7) would protect the myocardium from ischaemic injury. A single bolus of 3.5 × 10(8) transducing units of lenti-Ang-(1-7) was injected into the left ventricle of 5-day-old male Sprague-Dawley rats. At 6 weeks of age, MI was induced by ligation of the left anterior descending coronary artery. Four weeks after the MI, echocardiography and haemodynamic parameters were measured to assess cardiac function. Postmyocardial infarction, rats showed significant decreases in fractional shortening and dP/dt (rate of rise of left ventricular pressure), increases in left ventricular end-diastolic pressure, and ventricular hypertrophy. Also, considerable upregulation of cardiac angiotensin-converting enzyme (ACE) mRNA was observed in these rats. Lentivirus-mediated cardiac overexpression of Ang-(1-7) not only prevented all these MI-induced impairments but also resulted in decreased myocardial wall thinning and an increased cardiac gene expression of ACE2 and bradykinin B2 receptor (BKR2). Furthermore, in vitro experiments using rat neonatal cardiac myocytes demonstrated protective effects of Ang-(1-7) against hypoxia-induced cell death. This beneficial effect was associated with decreased expression of inflammatory cytokines (tumour necrosis factor-α and interleukin-6) and increased gene expression of ACE2, BKR2 and interleukin-10. Our findings indicate that overexpression of Ang-(1-7) improves cardiac function and attenuates left ventricular remodelling post-MI. The protective effects of Ang-(1-7) appear to be mediated, at least in part, through modulation of the cardiac renin-angiotensin system and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685447      PMCID: PMC3755594          DOI: 10.1113/expphysiol.2011.056994

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  48 in total

Review 1.  Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.

Authors:  Dilek Iusuf; Robert H Henning; Wiek H van Gilst; Anton J M Roks
Journal:  Eur J Pharmacol       Date:  2008-03-15       Impact factor: 4.432

2.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.

Authors:  T Tsutamoto; T Hisanaga; A Wada; K Maeda; M Ohnishi; D Fukai; N Mabuchi; M Sawaki; M Kinoshita
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

3.  Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).

Authors:  Robson A S Santos; Andréa S Haibara; Maria José Campagnole-Santos; Ana C Simões e Silva; Renata D Paula; Sérgio V B Pinheiro; Maria Fátima Leite; Virginia S Lemos; Denise M R Silva; Mateus T Guerra; Mahesh C Khosla
Journal:  Hypertension       Date:  2003-01-20       Impact factor: 10.190

4.  AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.

Authors:  Yoshihiko Oishi; Ryoji Ozono; Masao Yoshizumi; Masahiro Akishita; Masatsugu Horiuchi; Tetsuya Oshima
Journal:  Life Sci       Date:  2006-09-06       Impact factor: 5.037

5.  Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats.

Authors:  Annemarieke E Loot; Anton J M Roks; Robert H Henning; René A Tio; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

6.  Converting enzyme determines plasma clearance of angiotensin-(1-7).

Authors:  K Yamada; S N Iyer; M C Chappell; D Ganten; C M Ferrario
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

7.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

8.  Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.

Authors:  May Al-Maghrebi; Ibrahim F Benter; Debra I Diz
Journal:  Pharmacol Res       Date:  2008-12-31       Impact factor: 7.658

9.  Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology.

Authors:  Shant Der Sarkissian; Justin L Grobe; Lihui Yuan; Dhruv R Narielwala; Glenn A Walter; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2008-02-04       Impact factor: 10.190

10.  ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts.

Authors:  Justin L Grobe; Shant Der Sarkissian; Jillian M Stewart; J Gary Meszaros; Mohan K Raizada; Michael J Katovich
Journal:  Clin Sci (Lond)       Date:  2007-10       Impact factor: 6.124

View more
  36 in total

1.  Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.

Authors:  Vaibhav B Patel; Abhijit Takawale; Tharmarajan Ramprasath; Subhash K Das; Ratnadeep Basu; Maria B Grant; David A Hall; Zamaneh Kassiri; Gavin Y Oudit
Journal:  J Mol Med (Berl)       Date:  2015-04-15       Impact factor: 4.599

2.  Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.

Authors:  Yanfei Qi; Juan Zhang; Colleen T Cole-Jeffrey; Vinayak Shenoy; Andrew Espejo; Mina Hanna; Chunjuan Song; Carl J Pepine; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2013-08-19       Impact factor: 10.190

3.  Beneficial Effects of Angiotensin-(1-7) on CD34+ Cells From Patients With Heart Failure.

Authors:  Colleen T Cole-Jeffrey; Carl J Pepine; Michael J Katovich; Maria B Grant; Mohan K Raizada; Sugata Hazra
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

Review 4.  Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.

Authors:  Vaibhav B Patel; Jiu-Chang Zhong; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

5.  Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.

Authors:  Yanfei Qi; Hongwei Li; Vinayak Shenoy; Qiuhong Li; Fong Wong; Ling Zhang; Mohan K Raizada; Colin Sumners; Michael J Katovich
Journal:  Exp Physiol       Date:  2011-10-03       Impact factor: 2.969

6.  Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.

Authors:  E Bruce; V Shenoy; A Rathinasabapathy; A Espejo; A Horowitz; A Oswalt; J Francis; A Nair; T Unger; M K Raizada; U M Steckelings; C Sumners; M J Katovich
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

7.  Blockade of Endogenous Angiotensin-(1-7) in Hypothalamic Paraventricular Nucleus Attenuates High Salt-Induced Sympathoexcitation and Hypertension.

Authors:  Xiao-Jing Yu; Yu-Wang Miao; Hong-Bao Li; Qing Su; Kai-Li Liu; Li-Yan Fu; Yi-Kang Hou; Xiao-Lian Shi; Ying Li; Jian-Jun Mu; Wen-Sheng Chen; Wei Cui; Guo-Qing Zhu; Philip J Ebenezer; Joseph Francis; Yu-Ming Kang
Journal:  Neurosci Bull       Date:  2018-10-16       Impact factor: 5.203

Review 8.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

9.  Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.

Authors:  Mahmoud S Alghamri; Mariana Morris; J Gary Meszaros; Khalid M Elased; Nadja Grobe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

Review 10.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.